Komori
Transgenic Group (2342) · PolicyFirst stated

Role- and Performance-Based Personnel Evaluation and Development of Specialized Personnel

First written in FY2026. . Latest entry: FY2026.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Building a foundation for capability development through reforms to talent definitions and evaluation systemsA theme 173 companies write about · 0 as a headwind · 178 as a tailwind

21 other companies' latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 173 companies compared. The sentences above are computed from all 173.
Full recordFilings, disclosures and news, newest first
  1. FY2026First statedAnnual report

    「As a basic policy, the Company has established and operates personnel evaluation systems at each Group company to ensure fair evaluation and treatment based on employees’ roles and performance. The drug discovery support business is a highly specialized field, and the Company is engaged in relatively long-term capability development and talent cultivation.」

    The Company’s human resources strategy comprises evaluation and treatment based on roles and performance, as well as long-term capability development and talent cultivation in the drug discovery support field.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Transgenic Group yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Role- and Performance-Based Personnel Evaluation and Development of Specialized Personnel | TRANSGENIC GROUP INC. (2342) | Komori